gosset drugs
Search drugs and therapeutic assets by name, target, disease, modality, developer and phase. Names are resolved for you.
gosset drugs [NAME] [filters] [output flags]NAME (optional) is a drug name, brand or development code. Omit it to filter only.
Filters
| Flag | Accepts | Example |
|---|---|---|
NAME | drug name, brand, code or id | gosset drugs pembrolizumab · gosset drugs trodelvy |
--target | target name or id | --target PD-1 · --target "KRAS G12C" |
--disease | disease name or id; includes narrower diseases | --disease "atopic dermatitis" |
--modality | modality name or id | --modality ADC · --modality "monoclonal antibody" |
--company | developer name or id | --company AstraZeneca |
--phase | comma-separated phases | --phase 3 · --phase Approved,3 · --phase Preclinical |
--route | route(s) of administration | --route Oral · --route Subcutaneous |
--action | pharmacological direction | --action agonist · --action "Inverse agonist" |
--combination | how the actives are supplied | --combination fixed_dose |
--include-combinations | flag | also return trial-arm regimens (see below) |
--industry-only | flag | count only industry programs; needs --disease |
Phase values: Preclinical, 1, 2, 3, 4, Approved, Discontinued. With --disease, the phase is the phase in that disease.
Results are sorted most advanced first (Approved, then Phase 3, …). Change it with --sort, for example --sort=name.
More filters (developer type, ADC payload and linker, approval year, line of therapy, vaccine pathogen) are available through --where.
Examples
A target landscape
gosset drugs --target TL1A --tablename phase status targets diseases developers
----------------------- ----- ------ -------------------------------- ------------------------------------------------------------ ---------------------------------------
afimkibart 3 Active TL1A ulcerative colitis, crohn's disease, atopic dermatitis, rheu Roche, Roivant Sciences, Pfizer
duvakitug 3 Active TL1A, DR3 crohn's disease, ulcerative colitis, hidradenitis suppurativ Teva Pharmaceutical Industries, Sanofi
tulisokibart 3 Active TL1A ulcerative colitis, crohn's disease, hidradenitis suppurativ Merck
…
… showing 25 of 75 total# The TROP2 field, approved drugs first
gosset drugs --target TROP2 --limit 5 --fields name,phase,developers --tablename phase developers
---------------------- -------- ------------------------------------------------------------
datopotamab deruxtecan Approved Daiichi Sankyo, AstraZeneca
sacituzumab govitecan Approved Gilead Sciences
FDA018-ADC 3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
[18F]AlF-RESCA-T4 3 Renji Hospital, Shanghai Jiao Tong University
tizetatug rezetecan 3 Hengrui Therapeutics, Suzhou Suncadia Biopharmaceutical, Atr
… showing 5 of 202 totalThe fourth row is an imaging tracer. Diagnostics, generics and biosimilars are part of the database; see Notes for how to leave them out.
Filter by phase
gosset drugs --target PD-1 --phase Approved,3 --limit 5 --fields name,phase,developers --table
gosset drugs --target "KRAS G12C" --phase Preclinical --limit 3 --fields name,phase,developers --tablename phase developers
-------- ----------- ------------------------------------------------------------
BPI-2451 Preclinical Beta Pharma
EB-TM1 Preclinical Exollence Biotechnology, Exollence
KRB-456 Preclinical VCU Massey Cancer Center, Albert Einstein College of Medicin
… showing 3 of 25 totalTarget and disease together
gosset drugs --target TROP2 --disease "breast cancer" --limit 5 --fields name,phase,developers --tablename phase developers
----------------------- -------- ----------------------------------------------------
sacituzumab govitecan Approved Gilead Sciences
datopotamab deruxtecan Approved Daiichi Sankyo, AstraZeneca
sacituzumab tirumotecan 3 Klus Pharma, Merck, Sichuan Colombotai Biomedical
JSKN016 3 AlphaMab Oncology
ESG401 3 Essex Bio-Technology, Shanghai Escugen Biotechnology
… showing 5 of 68 total# Anti-amyloid antibodies in Alzheimer's disease
gosset drugs --target "amyloid beta" --modality "monoclonal antibody" \
--disease "alzheimer's disease" --limit 5 --fields name,phase,developers --tableA company's pipeline
gosset drugs --company AstraZeneca --modality ADC --limit 5 --fields name,phase,targets --tablename phase targets
---------------------- -------- ------------
datopotamab deruxtecan Approved TACSTD2
trastuzumab deruxtecan Approved ERBB2
torvutatug samrotecan 3 FOLR1
sonesitatug vedotin 3 Claudin 18.2
puxitatug samrotecan 3 VTCN1
… showing 5 of 36 totalOne drug
gosset drugs "datopotamab deruxtecan" --fields drug_id,name,phase,targets,developers[
{
"drug_id": "6753680d5ed849fb27bf3e90",
"name": "datopotamab deruxtecan",
"phase": "Approved",
"targets": ["TACSTD2"],
"developers": ["Daiichi Sankyo", "AstraZeneca"]
}
]Drop --fields to get the full record. A brand works too:
gosset drugs trodelvy --fields name,phase,targets --tablename phase targets
--------------------------------- ----------- --------------
sacituzumab govitecan Approved TACSTD2
sacituzumab + trastuzumab-vc-MMAE Preclinical ERBB2, TACSTD2A name matches every record for that drug, including fixed-dose products and preclinical combinations that contain it.
Industry programs in a disease
gosset drugs --disease "ulcerative colitis" --phase 3 --industry-only --limit 5 \
--fields name,phase,developers --tablename phase developers
------------ -------- -------------------------------------------
afimkibart 3 Roche, Roivant Sciences, Pfizer
obefazimod 3 Abivax
duvakitug 3 Teva Pharmaceutical Industries, Sanofi
tulisokibart 3 Merck
icotrokinra Approved Protagonist Therapeutics, Johnson & Johnson
… showing 5 of 36 total--industry-only counts only programs with an industry sponsor or collaborator in that disease. Without --disease it doesn't narrow anything.
Direction matters: --action
Without it, --target TrkA means "anything that acts on TrkA", so kinase inhibitors come back alongside the agonists you may be looking for.
gosset drugs --target TrkA --action agonist --limit 5 --fields name,phase,targets --tableagonist and antagonist include their sub-types. An "inverse agonist" counts as an antagonist, so pass the exact effect when that distinction matters:
gosset drugs --target 5-HT2A --action "Inverse agonist" --limit 5 --fields name,phase --tablename phase
------------------------------------ --------
risperidone (Janssen Pharmaceutical) Approved
pimavanserin Approved
efavirenz Approved
perospirone 4
mianserin 4
… showing 5 of 25 totalCombinations and regimens
By default gosset drugs hides trial-arm regimens: two or more drugs given together in a trial, such as cisplatin + vinflunine. Co-formulated products (fixed-dose combinations and mixtures) are always shown.
gosset drugs vinflunine --include-combinations --fields name,phase --tablename phase
----------------------------------- ------------
vinflunine 3
Vinflunine + capecitabine 3
vinflunine + gemcitabine 3
carboplatin + vinflunine 2
…--combination picks one kind: none (single agents), fixed_dose, mixture or co_administration (regimens). Pass a comma list for several.
gosset drugs --target GLP-1R --combination fixed_dose --limit 5 --fields name,phase,developers --tableConditions on the developer
--where reaches into related records. Private developers only:
gosset drugs --target KRAS --phase 2,3 --where developer.public=false --limit 5 \
--fields name,phase,developers --tablename phase developers
------------------- ----- ----------------------------------------------------------
DN-022150 3 Jiangxi Kvvit Pharmaceutical, Jiangxi Kerui Pharmaceutical
2-hydroxyoleic acid 3 Laminar Pharmaceuticals
sosimerasib 3 Jemincare, HUYABIO International, LLC.
HRS-7058 3 Shandong Shengdi Pharmaceutical
GFH375 3 GenFleet TherapeuticsLeave big pharma out:
gosset drugs --target TL1A --phase 2,3 --where 'company_type!=Big Pharma' --fields name,phase,developers --tableSee Query API for the full --where syntax.
Approvals by regulator
regulatory_approvals has one entry per regulator (FDA, EMA, PMDA, NMPA, MHRA and others). Each entry gives the agency's own approval number, approval_id Added 16 November 2026. approval_id: the approval number at each regulator, such as an NDA or EMA number., and the status of that approval, approval_status Added 16 November 2026. approval_status: whether an approval is active, withdrawn, suspended, expired or refused.: active, withdrawn, suspended, expired, refused, or unknown when the register does not publish one.
gosset drugs adagrasib --limit 1 --fields name,regulatory_approvals \
| jq '.[0].regulatory_approvals[] | select(.approval_id) | {agency, approval_id, approval_status, link_type}'{
"agency": "ema",
"approval_id": "EMEA/H/C/006013",
"approval_status": "active",
"link_type": "decision"
}
{
"agency": "orange_book",
"approval_id": "NDA216340",
"approval_status": "active",
"link_type": "decision"
}select(.approval_id) keeps the regulators that publish a number. Adagrasib also has entries for AIFA, Hong Kong and MHRA without one.
approval_status is not a filter. Fetch the field and select in jq, for example select(.approval_status == "withdrawn"). All keys are in the REST reference.
Vaccines
Filter vaccines by pathogen or by valency word with --where
combination_vaccine Added 16 November 2026. combination_vaccine: true when a vaccine protects against two or more different pathogens. to see whether a product protects against two or more different pathogens:
gosset drugs --where 'vaccine_pathogen=Bordetella pertussis' --phase Approved \
--fields name,combination_vaccine --limit 5 --tablename combination_vaccine
------------------------------------------------------------ -------------------
Td5cp True
DTaP5-HB-IPV-Hib vaccine True
diphtheria, tetanus, acellular pertussis and inactivated pol True
TETRActHib True
Pentaxim True
… showing 5 of 43 totalcombination_vaccine is true for products such as a hexavalent DTaP vaccine or MMR, and false for vaccines against one pathogen, even when they cover many serotypes (such as a 20-valent pneumococcal vaccine). It is left out when the composition does not give the pathogen count. Don't use is_combination for this question: it counts active substances, so a quadrivalent influenza vaccine can read true. The vaccine field has the full composition, with one entry per pathogen in components.
vaccine_valency takes monovalent, bivalent, trivalent, quadrivalent, pentavalent, hexavalent, nonavalent or multivalent.
Preclinical stage
--phase Preclinical covers everything before the first trial. preclinical_substage
how far a program has got, when a source states it: discovery, lead_optimisation, ind_enabling, ind_filed, or unspecified. It comes with the source link, its date and its own words.
Request it with --fields, for example --fields name,phase,preclinical_substage.
No preclinical_substage means no source we use states a stage. It does not mean the drug has none.
Line of therapy
--where line= keeps drugs tested in trials of that line of therapy for the disease you select. It needs --disease. Values are first-line, subsequent, maintenance, adjuvant and neoadjuvant; 2L, second line and relapsed all mean subsequent.
gosset drugs --disease "multiple myeloma" --where line=maintenance --phase 3,Approved \
--fields name,phase --limit 5 --tablename phase
------------- --------
dexamethasone Approved
bortezomib Approved
lenalidomide Approved
daratumumab Approved
pomalidomide Approved
… showing 5 of 44 totalPiping to jq
# Names of the Phase 3 TL1A drugs
gosset drugs --target TL1A --phase 3 | jq -r '.[].name'
# afimkibart
# duvakitug
# tulisokibart
# Name and developers as CSV
gosset drugs --target TROP2 --phase 3 \
| jq -r '.[] | [.name, (.developers | join("; "))] | @csv'
# Count a target's drugs by phase (--all fetches every row)
gosset drugs --target IL-23 --all --fields name,phase \
| jq 'group_by(.phase) | map({phase: .[0].phase, n: length})'Useful fields
Run gosset schema drugs for all of them. Common ones: drug_id, name, brand_names, code_names, phase, status, developers, targets, diseases, modalities, route, first_approval, next_catalyst_date, trial_count, patent_expiry, description, regulatory_approvals, fda_approval_table, accelerated_approval, vaccine, combination_vaccine, preclinical_substage.
Notes
- Diagnostics, generics and biosimilars are in the database and can appear in a target search. Narrow with
--phaseor--modality, or drop them with--where exclude_flags=is_combination,is_diagnostic,is_generic,is_biosimilar. Keepis_combinationin that list: yourexclude_flagsreplaces the default one that hides regimens. --include-idsaddstarget_ids,disease_class_idsand similar fields, for joining drugs to other records.